| Annual Financials | 2024 | 2025 | TTM |
Revenue  | 62 | 86 | 0 |
| Expenses | 55 | 71 | 0 |
| EBITDA | 7 | 15 | 0 |
| Operating Profit % | 10 % | 16 % | 0 % |
| Depreciation | 1 | 1 | 0 |
| Interest | 3 | 4 | 0 |
| Profit Before Tax | 3 | 10 | 0 |
| Tax | 1 | 3 | 0 |
| Net Profit | 2 | 8 | 0 |
| EPS in ₹ | 1.90 | 6.64 | 0.00 |
Neochem Bio Solutions
Neochem Bio Solutions
92.35
+1.30
(1.43%)
Market Cap
158.11 Cr
PE Ratio
20.10
Volume
9,600.00
Day High - Low
94.45 - 91.00
52W High-Low
121.00 - 63.00
Key Fundamentals
Market Cap
158.11 Cr
EPS
6.64
PE Ratio
20.10
PB Ratio
2.17
Book Value
41.89
EBITDA
15.10
Dividend Yield
0.00 %
Industry
Chemicals Sector
Specialty Chemicals Return on Equity
39.24
Debt to Equity
2.17
Actual
Company News
View All News
Neochem Bio Solutions Limited reported a 32% rise in FY26 revenue to INR110.7 crore. PAT grew 62% to INR12 crore with EBITDA margins expanding to 20.4%.
Neochem Bio FY26 PAT rises 62%
May 19, 2026
May 19, 2026Neochem Bio Solutions reported a 62% YoY rise in PAT to ₹1,203 lakh for FY26. Revenue grew 32% to ₹11,069 lakh.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,580.70 | #1 1,60,879.75 | 65.82 | 14,867.00 | 11.05 | #1 2,471 | 36.65 | 54.86 | |
2,741.60 | 81,267.83 | 44.82 | #1 15,893.60 | 7.20 | 1,835 | 10.63 | 50.61 | |
3,899.30 | 42,833.81 | 75.40 | 4,996.00 | 2.94 | 569 | -42.93 | 55.98 | |
7,637.00 | 39,159.04 | 59.66 | 3,313.90 | #1 38.48 | 664 | #1 123.79 | 56.25 | |
663.10 | 33,456.15 | 44.10 | 4,832.00 | 3.60 | 755 | 33.44 | 52.55 | |
1,667.20 | 22,739.45 | 40.69 | 7,887.07 | -5.72 | 566 | 8.54 | 55.23 | |
1,452.80 | 19,280.48 | 90.43 | 1,160.14 | 31.79 | 240 | 7.36 | 68.28 | |
6,264.00 | 18,442.32 | #1 26.64 | 0.00 | 10.21 | 0 | 62.26 | 37.60 | |
484.30 | 17,560.45 | 41.92 | 8,286.00 | 13.73 | 365 | 42.71 | 55.21 | |
5,024.00 | 15,403.57 | 36.75 | 2,365.80 | -0.04 | 403 | 21.01 | 51.18 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
39.03 %
Net Income Growth
333.33 %
Cash Flow Change
32.14 %
ROE
161.43 %
ROCE
117.68 %
EBITDA Margin (Avg.)
58.55 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 |
| Total Assets | 64 | 79 |
| Fixed Assets | 19 | 19 |
| Current Assets | 39 | 53 |
| Capital Work in Progress | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 45 | 60 |
| Total Equity & Liabilities | 64 | 79 |
| Current Liabilities | 33 | 44 |
| Non Current Liabilities | 19 | 15 |
| Total Equity | 12 | 20 |
| Reserve & Surplus | 5 | 13 |
| Share Capital | 7 | 7 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | -0 |
| Investing Activities | -3 | -8 | -2 |
| Operating Activities | -1 | 2 | 3 |
| Financing Activities | 4 | 6 | -1 |
Share Holding
| % Holding | Aug 2025 | Nov 2025 | Dec 2025 | Mar 2026 |
| Promoter | 91.12 % | 91.12 % | 91.12 % | 66.72 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.18 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 15.82 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 0.00 % | 10.93 % |
| Others | 8.88 % | 8.88 % | 8.88 % | 6.35 % |
| No of Share Holders | 14 | 14 | 14 | 406 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 18 May 2026 |  Quarterly Result Announcement | NA | 18 May 2026 | 86.60 | 93.60 |
Technical Indicators
RSI(14)
Neutral 40.79
ATR(14)
Less Volatile 4.63
STOCH(9,6)
Oversold 18.42
STOCH RSI(14)
Oversold 0.14
MACD(12,26)
Bearish -1.48
ADX(14)
Weak Trend 12.60
UO(9)
Bearish 37.62
ROC(12)
Downtrend And Accelerating -14.51
WillR(14)
Oversold -92.53
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
